Time / Room | Vista 1 | Vista 2 | Vista 3 | Grand 1 | Grand 4+5 | Walker 1 |
09:00-10:30 | Symposium 01 KASL Distinguished papers of 2023-2024 in clinical and molecular hepatology | Symposium 02 KSG Gender-specific medicine in gastroenterology & hepatology | Multidisciplinary Symposium 01 KSGE Current insights into obesity and metabolic disorder treatment | Symposium 03 KSNM New pathogenic factors beyond motility disorders in functional dyspepsia | Symposium 04 KASID Optimal management strategies for lower gastrointestinal emergencies | Symposium 05 KSGC Clinical applications of artificial intelligence and OMICS in translational research |
10:30-10:50 | Opening Ceremony | Coffee Break | ||||
10:50-12:20 |
Coffee Break (10:50-11:10) |
Symposium 06 KSGCommon adverse events associated with medications and precautions in gastroenterology & hepatology | Symposium 07 KSGEDiagnosis and management of lower gastrointestinal bleeding | Symposium 08 KSNM Updates on the diagnosis and management of GERD 2024 | Symposium 09 KASID Inflammatory bowel disease: translating insights into better patient outcomes | Symposium 10 KSGC The best way to prevent colon cancer and its recurrence |
Chung Yong Kim Memorial Lecture
KASL
(11:10-11:40)
General Meeting KASL (11:40-12:40) |
||||||
12:20-12:40 | ||||||
12:40-13:20 |
Luncheon Symposium 01 |
|||||
13:20-14:50 | Symposium 11 KASL Emerging issues in the management of portal hypertension | Combined Symposium 01 KSG+KASIDManagement of lower GI disorders in special populations | Basic/Translational Symposium KASL Advancements in liver research: from experimental models to clinical insights and therapeutic targets | Presidential Lecture KSNM | Free Paper 02 PB 01 | Free Paper 04 Oncology 01 |
Free Paper 01 FGID/Motility 01 | Free Paper 03 PB 02 | Free Paper 05 Oncology 02 | ||||
14:50-15:10 | Coffee Break | |||||
15:10-16:40 | Symposium 12 KASL Careful insights for benign hepatic neoplasm | Combined Symposium 02 KSG+KCHUGRCutting-edge diagnosis of upper GI diseases | Free Paper 06 FGID/Motility 02 | Free Paper 08 LGI 01 | Free Paper 09 Oncology 03 | |
Free Paper 07 FGID/Motility 03 |